301 related articles for article (PubMed ID: 2867250)
1. [MI cholinergic receptors of gastric secretion: current status].
Vatier J
J Pharmacol; 1985; 16 Suppl 2():145-69. PubMed ID: 2867250
[TBL] [Abstract][Full Text] [Related]
2. Effects of pirenzepine and atropine on vagal and cholinergic gastric secretion and gastrin release and on heart rate in the dog.
Hirschowitz BI; Fong J; Molina E
J Pharmacol Exp Ther; 1983 May; 225(2):263-8. PubMed ID: 6132990
[TBL] [Abstract][Full Text] [Related]
3. Role of the cholinergic nervous system in acid secretion.
Chan CB; Soll AH
Pharmacology; 1988; 37 Suppl 1():17-21. PubMed ID: 2467315
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological analysis of the muscarinic receptors involved when McN-A 343 stimulates acid secretion in the mouse isolated stomach.
Black JW; Shankley NP
Br J Pharmacol; 1985 Nov; 86(3):609-17. PubMed ID: 2415197
[TBL] [Abstract][Full Text] [Related]
5. [Effects of propiverine hydrochloride (propiverine) on the muscarinic receptor binding affinity in guinea pig tissues and on salivation in conscious dogs].
Nagao M; Kaneko S; Hirota T; Isogai M; Shimizu H
Nihon Yakurigaku Zasshi; 1999 Mar; 113(3):157-66. PubMed ID: 10347840
[TBL] [Abstract][Full Text] [Related]
6. Pirenzepine-sensitive muscarinic receptors regulate gastric somatostatin and gastrin.
Sue R; Toomey ML; Todisco A; Soll AH; Yamada T
Am J Physiol; 1985 Feb; 248(2 Pt 1):G184-7. PubMed ID: 2857528
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological evidence for selective inhibition of gastric acid secretion by telenzepine, a new antimuscarinic drug.
Eltze M; Gönne S; Riedel R; Schlotke B; Schudt C; Simon WA
Eur J Pharmacol; 1985 Jun; 112(2):211-24. PubMed ID: 4029260
[TBL] [Abstract][Full Text] [Related]
8. Control of acid secretion.
Schubert ML; Shamburek RD
Gastroenterol Clin North Am; 1990 Mar; 19(1):1-25. PubMed ID: 1691738
[TBL] [Abstract][Full Text] [Related]
9. Gallamine binding to muscarinic M1 and M2 receptors, studied by inhibition of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to rat brain membranes.
Burke RE
Mol Pharmacol; 1986 Jul; 30(1):58-68. PubMed ID: 3755217
[TBL] [Abstract][Full Text] [Related]
10. Gastric antisecretory and pharmacologic properties of N,N-dimethyl-N'-(2-diisopropylaminoethyl)-N-(4,6-dimethyl-2-pyridyl)ur ea (L-634,366).
Torchiana ML; Cook PG; Hanson CA; Wesley CA; Westrick BL; Wiese SR; Risley EA; Williams M
Arch Int Pharmacodyn Ther; 1986 May; 281(1):120-33. PubMed ID: 2875693
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological analysis of the inhibition by pirenzepine and atropine of vagal-stimulated acid secretion in the isolated stomach of the mouse.
Black JW; Shankley NP
Br J Pharmacol; 1986 May; 88(1):291-7. PubMed ID: 3754779
[TBL] [Abstract][Full Text] [Related]
12. Effect of pirenzepine on L--amino acids stimulated gastric acid secretion and serum gastrin levels in peptic ulcer disease in men.
Bertoglio S; Anfossi A; Arnulfo G; Valentini P; Berti Riboli E
Scand J Gastroenterol Suppl; 1982; 72():179-84. PubMed ID: 6957988
[TBL] [Abstract][Full Text] [Related]
13. [A selective antimuscarinic agent: pirenzepine. Review of its pharmacologic and clinical properties].
Del Tacca M; Danesi R; Blandizzi C; Bernardini MC
Minerva Dietol Gastroenterol; 1989; 35(3):175-89. PubMed ID: 2574837
[TBL] [Abstract][Full Text] [Related]
14. Effects of cimetidine, atropine and pirenzepine on basal and stimulated gastric acid secretion in the rat.
Ekelund M; Håkanson R; Vallgren S
Eur J Pharmacol; 1987 Jun; 138(2):225-32. PubMed ID: 3622610
[TBL] [Abstract][Full Text] [Related]
15. Muscarinic M2 stimulation releases histamine in the totally isolated, vascularly perfused rat stomach.
Sandvik AK; Kleveland PM; Waldum HL
Scand J Gastroenterol; 1988 Nov; 23(9):1049-56. PubMed ID: 2470130
[TBL] [Abstract][Full Text] [Related]
16. Effect on gastric secretion, gastrin and histamine release during and after long-term treatment by pirenzepine in dogs.
Vatier J; Riquet W; Célice-Pingaud C; Olivier A; Mignon M; Farinotti R
Fundam Clin Pharmacol; 1996; 10(2):144-50. PubMed ID: 8737957
[TBL] [Abstract][Full Text] [Related]
17. Pirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase.
Gil DW; Wolfe BB
J Pharmacol Exp Ther; 1985 Mar; 232(3):608-16. PubMed ID: 2579230
[TBL] [Abstract][Full Text] [Related]
18. Comparison of telenzepine, pirenzepine and atropine on gastric acid and pepsin secretion in response to histamine, pentagastrin, bethanechol, sham-feeding and feeding.
Konturek SJ; Tasler J; Cieszkowski M; Szewczyk K; Kromer W
Digestion; 1989; 44(2):66-78. PubMed ID: 2575551
[TBL] [Abstract][Full Text] [Related]
19. On the muscarinic receptors in the urinary bladder and the putative subclassification of muscarinic receptors.
Nilvebrant L
Acta Pharmacol Toxicol (Copenh); 1986; 59 Suppl 1():1-45. PubMed ID: 3524114
[TBL] [Abstract][Full Text] [Related]
20. Does pirenzepine distinguish between 'subtypes' of muscarinic receptors?
Szelenyi I
Br J Pharmacol; 1982 Dec; 77(4):567-9. PubMed ID: 6897522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
